One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
One Biosciences has raised $3.8M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
One Biosciences's investors include Invus, Redmile Group, Sofinnova Partners, Kima Ventures, Polytechnique Ventures.
One Biosciences is headquartered in Paris, France.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
One Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"One Biosciences — Funding & Investors." VCBacked, September 10, 2026, https://www.vcbacked.co/company/one-biosciences. Accessed October 18, 2026.
VCBacked. (2026). One Biosciences — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/one-biosciences
{{cite web |title=One Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/one-biosciences |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated